Similarly, inhibition of the mammalian target of rapamycin (mTOR) or the combined inhibition of PI3K and extracellular signal-regulated kinase 1 and 2 (ERK1/2) has been shown to protect GBM cells from ischemic stress [7, 8]. The gene discussed is PIK3CA; the disease is glioblastoma.